Absci (ABSI) Return on Invested Capital (2021 - 2026)
Absci (ABSI) reported Return on Invested Capital of 0.04% for Q1 2026, up 14.0% on a YoY basis from 0.03% in Q1 2025, and down 23.26% sequentially from 0.03% in Q4 2025.
Absci (ABSI) Return on Invested Capital (2021 - 2026) Analysis & Trends
Absci (ABSI) has 6 years of Return on Invested Capital data on file, last reported at 0.04% in Q1 2026.
- For the quarter ending Q1 2026, Return on Invested Capital rose 14.0% year-over-year to 0.04%; the trailing twelve-month figure through Mar 2026 stood at 0.04% (up 14.0% YoY), and the FY2024 full-year result was 2.74%, down 213.0% from the prior year.
- Return on Invested Capital declined to 0.04% in Q1 2026, from 0.03% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 0.03% in Q4 2025 to a low of 2.74% in Q4 2024.
- A 5-year average of 0.57% and a median of 0.23% in 2022 frame the typical range for Return on Invested Capital.
- Across the five-year window, Return on Invested Capital slumped 213 bps in 2024 and soared 271 bps in 2025, its largest moves.
- Tracing ABSI's Return on Invested Capital over 5 years: stood at 0.23% in 2022, then plunged by 162 bps to 0.61% in 2023, then plunged by 346 bps to 2.74% in 2024, then jumped by 99 bps to 0.03% in 2025, then decreased by 23 bps to 0.04% in 2026.
- Business Quant data shows ABSI's Return on Invested Capital at 0.04% in Q1 2026, 0.03% in Q4 2025, and 0.04% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.04% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Absci | 1.23 Bn | 1.11 Bn | - | -0.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.04% |
| Dec 31, 2025 | -0.03% |
| Sep 30, 2025 | -0.04% |
| Jun 30, 2025 | -0.06% |
| Mar 31, 2025 | -0.18% |
| Dec 31, 2024 | -2.74% |
| Sep 30, 2024 | -1.45% |
| Jun 30, 2024 | -1.37% |
| Mar 31, 2024 | -1.60% |
| Dec 31, 2023 | -0.61% |
| Sep 30, 2023 | -0.37% |
| Jun 30, 2023 | -0.38% |
| Mar 31, 2023 | -0.33% |
| Dec 31, 2022 | -0.23% |
| Sep 30, 2022 | -0.12% |
| Jun 30, 2022 | -0.07% |
| Mar 31, 2022 | -0.05% |
| Dec 31, 2021 | -0.05% |
| Sep 30, 2021 | -0.05% |
| Jun 30, 2021 | -0.10% |